Bristol-Myers Squibb (BMY) Tops Q1 EPS by 20c; Adjusts FY15 EPS Outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/10/2026

1. HUM
2. SPCX
3. ALHC
4. T
5. PEP
6. CVS
7. UNH
8. AXP
9. ZETA
10. DAL

Go back to Bristol-Myers Squibb (BMY) Tops Q1 EPS by 20c; Adjusts FY15 EPS Outlook

Bristol-Myers Squibb Reports First Quarter Financial Results

April 28, 2015 7:30 AM EDT

Reports Revenues of $4.0 Billion in the First Quarter Posts First Quarter GAAP and Non-GAAP EPS of $0.71 Achieves Key Data and Regulatory Milestones Across Portfolio Completes Strategic Transactions in Immuno-Oncology and Cardiovascular, Supporting the Companys Evolving Portfolio Adjusts 2015 GAAP EPS Guidance Range to $0.96 - $1.06 and Non-GAAP EPS Guidance Range to $1.60 - $1.70

NEW YORK--(BUSINESS WIRE)--... More